Prevalence and correlates of depressive symptoms in HIV-positive patients: a cross-sectional study among newly diagnosed patients in Yaoundé, Cameroon

Rodrigue Minya L'akoa, Jean Jacques N Noubiap, Yixin Fang, Félicien Enyime Ntone, Christopher Kuaban, Rodrigue Minya L'akoa, Jean Jacques N Noubiap, Yixin Fang, Félicien Enyime Ntone, Christopher Kuaban

Abstract

Background: Depression is one of the most common neuropsychiatric complications of HIV disease, and in turn it is associated with worse HIV-related outcomes. Data on depression among HIV-infected patients in Cameroon are scarce. In this study, we report the prevalence and correlates of depressive symptoms among newly diagnosed HIV-infected patients in Yaoundé, Cameroon.

Methods: Interviews were conducted with 100 newly diagnosed HIV-infected patients at three referral hospitals of Yaoundé. Depression was assessed using the nine-item Patient Health Questionnaire (PHQ-9). A positive depression screen was defined as PHQ-9 score greater than 9.

Results: The overall prevalence of depressive symptoms was 63% (95% CI: 53.2 to 71.8), the majority having symptoms corresponding to moderate depression. Multiple logistic regression analysis showed that probable depressed patients were more likely than those who were not depressed to have had experience of alcohol abuse (OR: 19.03, 95% CI 3.11-375.85; p = 0.0083), and a 100 CD4 cells/mm3 fewer was associated with a 2.9 times increase of the odds of probable depression (95% CI 1.88-4.84; p < 0.0001).

Conclusions: Our findings indicate a high prevalence of depressive symptoms in newly diagnosed HIV-infected patients in our setting, and their association with alcohol abuse and severe immunosuppression. This study also highlights the necessity to integrate mental health interventions into routine HIV clinical care in Cameroon.

References

    1. UNAIDS. UNAIDS world AIDS Day report, 2011. Joint United Nations programme on HIV/AIDS (UNAIDS) 2011. .
    1. UNAIDS. Global plan towards the Elimination of New HIV infections among children by 2015 and keeping their mothers Alive 2011–2015. Joint United Nations programme on HIV/AIDS (UNAIDS) 2011. .
    1. UNAIDS. UNAIDS report on the global AIDS epidemic 2010. 2010. .
    1. Tate D, Paul RH, Flanigan TP, Tashima K, Nash J, Adair C, Boland R, Cohen RA. The impact of apathy and depression on quality of life in patients infected with HIV. AIDS Patient Care STDs. 2003;17(3):115–120. doi: 10.1089/108729103763807936.
    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. Plos Med. 2006;3(11):2011–2030.
    1. Campos LN, Guimaraes MD, Remien RH. Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS Behav. 2008;14:289–299.
    1. Savetsky JB, Sullivan LM, Clarke J, Stein MD, Samet JH. Evolution of depressive symptoms in human immunodeficiency virus-infected patients entering primary care. J Nerv Ment Dis. 2001;189(2):76–83. doi: 10.1097/00005053-200102000-00002.
    1. World Health Organisation. Health topics: depression. .
    1. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158:725–730. doi: 10.1176/appi.ajp.158.5.725.
    1. Katon WJ. Clinical and health services relationships between major depression, de pressive symptoms, and general medical illness. Biol Psychiatry. 2003;54:216–226. doi: 10.1016/S0006-3223(03)00273-7.
    1. Sherbourne CD, Hays RD, Fleishman JA, Vitiello B, Mugruder KM, Bing EG, McCaffrey D, Burnam A, Longshore D, Eggan F, Bozzette SA, Shapiro MF. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157:248–254. doi: 10.1176/appi.ajp.157.2.248.
    1. Wulsin LR, Vaillant GE, Wells VE. A systematic review of the mortality of depression. Psychosom Med. 1999;61:6–17.
    1. Treisman G, Angelino A. Interrelation between psychiatric disorders and the prevention and treatment of HIV infection. Clin Infect Dis. 2007;45(Suppl 4):S313–S317.
    1. Sternhell PS, Corr MJ. Psychiatric morbidity and adherence to antiretroviral medication in patients with HIV/AIDS. Aust N Z J Psychiatry. 2002;36:528–533. doi: 10.1046/j.1440-1614.2002.00999.x.
    1. Paterson DL, Swindells S, Mohr J. et al.Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.
    1. Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry. 2003;54:295–306. doi: 10.1016/S0006-3223(03)00323-8.
    1. Gaynes BN, Pence BW, Atashili J, O’Donnell J, Kats D, Ndumbe PM. Prevalence and predictors of major depression in HIV-infected pateints on antiretroviral therapy in Bamenda, a semi-urban center in Cameroon. PloS One. 2012;7(7):e41699. doi: 10.1371/journal.pone.0041699.
    1. Bureau central des recensements et des études de population du Cameroun. Rapport de présentation des résultats définitifs de 3ème recesement général de la population humaine. .
    1. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984;252(14):1905–1907. doi: 10.1001/jama.1984.03350140051025.
    1. Amaral RA, Malbergiera A. Evaluation of a screening test for alcohol-related problems (CAGE) among employees of the campus of the University of Sao Paulo. Rev Bras Psiquiatr. 2004;26(3):156–163.
    1. American Psychiatric Association (APA) Diagnostic and statistical manual of mental disorders, fourth Edition (DSM-IV) criteria for major depressive episode. Washington DC: APA; 1994.
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. Kinyanda E, Hoskins S, Nakku J, Nawaz S, Patel V. Prevalence and risk factors of major depressive disorder in HIV/AIDS as seen in semi-urban Entebbe district, Uganda. BMC Psychiatry. 2011;11:205. doi: 10.1186/1471-244X-11-205.
    1. Bumham KP, Anderson DR. Model selection and multimodel inference: a practical information-theoretic approach. 2. New York: Springer Verlag; 2002.
    1. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ. 2007;85:867–872.
    1. Freeman M, Patel V, Collins PY, Bertolote J. Integrating mental health in global initiatives for HIV/AIDS. Br J Psychiatry. 2005;187:1–3. doi: 10.1192/bjp.187.1.1.
    1. Ouedraogo A, Sanou PT. Anxiété et dépression chez les personnes vivant avec le VIH en milieu africain à Ouagadougou, Burkina Faso. Psychopathol Africaine. 2002;31:333–344.
    1. Kaharuza FM, Bunnell R, Moss S, Purcell DW, Bikaako-Kajura W, Wamai N. Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav. 2006;10:105–111.
    1. Bhatia R. Person newly diagnosed with HIV infection are at high risk of depression and poor linkage to care: results from the steps study. AIDS Behav. 2010;8:1–10.
    1. Lyketsos CG, Hanson A, Fishman M, McHugh PR, Treisman GJ. Screening for psychiatric morbidity in a medical outpatient clinic for HIV infection: the need for a psychiatric presence. Int J Psychiatry Med. 1994;24(2):103–113. doi: 10.2190/URTC-AQVJ-N9KG-0RL4.
    1. Cleary PD, Singer E, Rogers TF, Avorn J, Van Devanter N, Soumerai S, Perry S, Pindyck J. Sociodemographic and behavioral characteristics of HIV antibody-positive blood donors. Am J Public Health. 1988;78(8):953–957. doi: 10.2105/AJPH.78.8.953.
    1. Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA. 1993;270:2568–2573. doi: 10.1001/jama.1993.03510210054027.
    1. Adewuya AO, Afolabi MO, Ola BA, Ogundele OA, Ajibare AO, Oladipo BF. Psychiatric disorders among the HIV-positive population in Nigeria: a control study. J Psychosom Res. 2007;63:203–206. doi: 10.1016/j.jpsychores.2007.03.006.
    1. Freeman M, Nkomo N, Kafaar Z, Kelly K. Factors associated with prevalence of mental disorder in people living with HIV/AIDS in South Africa. AIDS Care. 2007;19:1201–1209. doi: 10.1080/09540120701426482.
    1. Chandra PS, Ravi V, Desai A, Subbakrishna DK. Anxiety and depression among HIV-infected heterosexuals–a report from India. J Psychosom Res. 1998;45(5):401–409. doi: 10.1016/S0022-3999(98)00028-2.
    1. Nyamathi A, Heravian A, Zolt-Gilburne J, Zolt-Gilburna J, Sinha S, Ganguly K, Liu E, Ramakrishnan P, Marfisee M, Leake B. Correlates of depression among rural women living with AIDS in Southern India. Issues Ment Health Nurs. 2011;32(6):385–391. doi: 10.3109/01612840.2011.577269.
    1. Bolton P, Bass J, Neugebauer R, Verdeli H, Clouggherty KF, Wickramaratne P, Speelman L, Ndogoni L, Weissman M. Group interpersonal psychotherapy for depression in rural Uganda: a randomized controlled trial. JAMA. 2003;289(23):3117–3124. doi: 10.1001/jama.289.23.3117.
    1. Chan I, Kong P, Leung P, Au A, Li P, Chung R, PO LM, Yu P. Cognitive-behavioral group program for Chinese heterosexual HIV-infected men in Hong Kong. Patient Educ Couns. 2005;56(1):78–84. doi: 10.1016/j.pec.2003.12.010.
    1. Mbuagbaw L, Thabane L, Ongolo-Zogo P, Yondo D, Noorduyn S, Smieja M, Dolovich L. Trends and determining factors associated with adherence to antiretroviral therapy (ART) in Cameroon: a systematic review and analysis of the CAMPS trial. AIDS Res Ther. 2012;9(1):37. doi: 10.1186/1742-6405-9-37.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj